FDA Selects Agilent’s Dual-Mode Platform for MAQC Project

News   Jan 13, 2006

 
FDA Selects Agilent’s Dual-Mode Platform for MAQC Project
 
 
FURTHER INFORMATION
 
 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Microfluidics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE